Speaker illustration

Doctor Robert Zweigerdt

Hannover Medical School, Hannover (Germany)

Opportunities and limitations of iPSC technology in cardiovascular disease

Event: ESC Congress 2017

Topic: Stem cells and cell therapy

Session: Cardiac regeneration and disease modelling with induced Pluripotent Stem Cells (iPSC)

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb